Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches
Paul R. Territo, Hamideh Zarrinmayeh
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration
Fangjie Shao, Xiaoyu Wang, Haijian Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 139
Monoamine Neurotransmitters Control Basic Emotions and Affect Major Depressive Disorders
Yao Jiang, Di Zou, Yumeng Li, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1203-1203
Open Access | Times Cited: 109
Neuroinflammation Following Traumatic Brain Injury: Take It Seriously or Not
Ruizhe Zheng, Kuin-yu Lee, Zengxin Qi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 66
Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases
Emmanuel Moyse, Slavica Krantic, Nesrine Djellouli, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 48
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Luca Soraci, Maria Elsa Gambuzza, Leonardo Biscetti, et al.
Journal of Neurology (2022) Vol. 270, Iss. 3, pp. 1346-1360
Open Access | Times Cited: 30
A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists
Simran Soni, Mihir S. Lukhey, Baban S. Thawkar, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 4643-4656
Closed Access | Times Cited: 7
Calcitriol attenuates lipopolysaccharide-induced neuroinflammation and depressive-like behaviors by suppressing the P2X7R/NLRP3/caspase-1 pathway
Changshui Wang, Changmeng Cui, Xin Xie, et al.
Psychopharmacology (2024) Vol. 241, Iss. 7, pp. 1329-1343
Closed Access | Times Cited: 6
Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells
Sergei Kozlovskiy, Еvgeny А. Pislyagin, Ekaterina S. Menchinskaya, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 47-47
Open Access | Times Cited: 14
Microglial Autophagic Dysregulation in Traumatic Brain Injury: Molecular Insights and Therapeutic Avenues
Nargis Bano, Sameera Khan, Shakir Ahamad, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Mechanisms of astrocytic and microglial purinergic signaling in homeostatic regulation and implications for neurological disease
Moawiah M. Naffaa
Exploration of neuroscience (2025)
Open Access
The P2X7 Receptor, a Multifaceted Receptor in Alzheimer’s Disease
Kaitryn E. Ronning, Paul-Alexandre Déchelle-Marquet, Yueshen Che, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11747-11747
Open Access | Times Cited: 12
Leveraging the ATP‐P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications
Yaling Yin, Linyu Wei, Emily A. Caseley, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1346-1373
Open Access | Times Cited: 11
The Coming of Age of the P2X7 Receptor in Diagnostic Medicine
Francesco Di Virgilio, Valentina Vultaggio-Poma, Simonetta Falzoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9465-9465
Open Access | Times Cited: 11
P2X7 Receptor and Purinergic Signaling: Orchestrating Mitochondrial Dysfunction in Neurodegenerative Diseases
A. S. Zelentsova, Alexey V. Deykin, Vladislav O. Soldatov, et al.
eNeuro (2022) Vol. 9, Iss. 6, pp. ENEURO.0092-22.2022
Open Access | Times Cited: 16
Novel Strategies in the Early Detection and Treatment of Endothelial Cell-Specific Mitochondrial Dysfunction in Coronary Artery Disease
Weiqian E. Lee, Elijah Genetzakis, Gemma A. Figtree
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1359-1359
Open Access | Times Cited: 9
PET imaging of neuroinflammation: any credible alternatives to TSPO yet?
Fabien Chauveau, Alexandra Winkeler, Sylvie Chalon, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 3
Microglia-induced neuroinflammation in hippocampal neurogenesis following traumatic brain injury
Seyedeh Parisa Navabi, Firuzeh Badreh, Maryam Khombi Shooshtari, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35869-e35869
Open Access | Times Cited: 3
Development and clinical translation of P2X7 receptor antagonists: A potential therapeutic target in coronary artery disease?
Elijah Genetzakis, Jayson Gilchrist, Michael Kassiou, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108228-108228
Closed Access | Times Cited: 14
Tumour immune escape via P2X7 receptor signalling
Ricardo M. Sainz, Jorge Humberto Rodríguez-Quintero, María C. Maldifassi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
The Purinergic P2X7 Receptor as a Target for Adjunctive Treatment for Drug-Refractory Epilepsy
Divyeshz Thakku Sivakumar, Krishi Jain, Noura Alfehaid, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6894-6894
Open Access | Times Cited: 2
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons
Rachael Bartlett, Diane Ly, Neil R. Cashman, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 4, pp. 451-467
Open Access | Times Cited: 11
Inflammasome activation and assembly in Huntington’s disease
Tiago de Oliveira Furlam, Isadora Gonçalves Roque, Ewelin Wasner Machado da Silva, et al.
Molecular Immunology (2022) Vol. 151, pp. 134-142
Closed Access | Times Cited: 10
Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy
Caterina Claudia Lepre, Marina Russo, Maria Consiglia Trotta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9721-9721
Open Access | Times Cited: 4
Activation of the microglial P2X7R/NLRP3 inflammasome mediates central sensitization in a mouse model of medication overuse headache
Yanyun Wang, Liang Dong, Yun Zhang, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 4
Mesenchymal Stem Cells and Purinergic Signaling in Autism Spectrum Disorder: Bridging the Gap between Cell-Based Strategies and Neuro-Immune Modulation
Agata Wikarska, Kacper Roszak, Katarzyna Roszek
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1310-1310
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top